DIAGNOS Unveils Private Placement Initiative

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Sep 03 2025

0mins

Source: Globenewswire

Private Placement Announcement: Diagnos Inc. has announced a non-brokered private placement of 10 units at $10,000 each, aiming to raise $100,000 for product development and commercialization of AI-based screening services.
Details of the Units: Each unit includes a $10,000 unsecured convertible debenture with a 12-month term and 10,000 stock warrants, allowing conversion into common shares at specified prices.
Director Participation: A director of the Corporation has committed to subscribe for all units in the private placement, which is subject to regulatory approvals and a 4-month hold period on the securities.
Company Overview: Diagnos is focused on early detection of eye-related health issues using AI technology to enhance diagnostic accuracy and improve patient outcomes globally.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.